Filing Details
- Accession Number:
- 0001946439-23-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-16 18:13:34
- Reporting Period:
- 2023-11-15
- Accepted Time:
- 2023-11-16 18:13:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1946439 | Krista Davis | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp, Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-15 | 2,622 | $53.81 | 32,587 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $53.80 to $53.91, inclusive.
Billionaire Hedge Funds
